Biotest AG
BIESF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $108 | $108 | $117 | $104 |
| Short-Term Investments | $12 | $10 | $20 | $13 |
| Receivables | $202 | $197 | $169 | $152 |
| Inventory | $480 | $419 | $294 | $245 |
| Other Curr. Assets | $9 | $22 | $37 | $18 |
| Total Curr. Assets | $810 | $757 | $619 | $522 |
| Property Plant & Equip (Net) | $571 | $476 | $548 | $550 |
| Goodwill | $6 | $6 | $7 | $7 |
| Intangibles | $11 | $2 | $9 | $4 |
| Long-Term Investments | -$10 | $11 | -$15 | -$9 |
| Tax Assets | $20 | $10 | $1 | $10 |
| Other NC Assets | $27 | $149 | $34 | $19 |
| Total NC Assets | $625 | $654 | $584 | $582 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,434 | $1,411 | $1,203 | $1,104 |
| Liabilities | – | – | – | – |
| Payables | $88 | $78 | $51 | $39 |
| Short-Term Debt | $6 | $232 | $9 | $35 |
| Tax Payable | $4 | $4 | $3 | $1 |
| Deferred Revenue | $0 | $1 | $65 | $57 |
| Other Curr. Liab. | $62 | $72 | $2 | -$25 |
| Total Curr. Liab. | $160 | $385 | $130 | $106 |
| LT Debt | $592 | $382 | $565 | $496 |
| Deferred Rev, NC | $0 | $0 | $136 | $127 |
| Deferred Tax Liab, NC | $1 | $0 | $1 | $2 |
| Other NC Liab. | $151 | $145 | $136 | $121 |
| Total NC Liab. | $743 | $527 | $702 | $617 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $59 | $58 | $29 | $27 |
| Total Liabilities | $903 | $912 | $832 | $724 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $2 | $2 |
| Common Stock | $40 | $40 | $40 | $40 |
| Retained Earnings | $275 | $240 | $112 | $121 |
| AOCI | $0 | $1 | -$2 | -$2 |
| Other Equity | $217 | $219 | $220 | $220 |
| Total Equity | $531 | $499 | $371 | $380 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,434 | $1,411 | $1,203 | $1,104 |
| Net Debt | $489 | $506 | $458 | $427 |